KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Organon (OGN) EBIAT (2020 - 2025)

Organon (OGN) has 6 years of EBIAT data on record, last reported at -$205.0 million in Q4 2025.

  • For Q4 2025, EBIAT fell 288.07% year-over-year to -$205.0 million; the TTM value through Dec 2025 reached $187.0 million, down 78.36%, while the annual FY2025 figure was $187.0 million, 78.36% down from the prior year.
  • EBIAT reached -$205.0 million in Q4 2025 per OGN's latest filing, down from $160.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $546.0 million in Q4 2023 and bottomed at -$205.0 million in Q4 2025.
  • Average EBIAT over 5 years is $217.1 million, with a median of $201.5 million recorded in 2021.
  • Peak YoY movement for EBIAT: skyrocketed 518.97% in 2024, then plummeted 288.07% in 2025.
  • A 5-year view of EBIAT shows it stood at $202.0 million in 2021, then plummeted by 46.53% to $108.0 million in 2022, then soared by 405.56% to $546.0 million in 2023, then crashed by 80.04% to $109.0 million in 2024, then tumbled by 288.07% to -$205.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$205.0 million in Q4 2025, $160.0 million in Q3 2025, and $145.0 million in Q2 2025.